Post by CLIRNET

76,661 followers

π‚πƒπ’π‚πŽ has approved π’π¨π­π¨π«πšπ¬π’π› πŸπŸ’πŸŽ 𝐦𝐠 for adults with πŠπ‘π€π’ π†πŸπŸπ‚β€“mutated locally advanced or metastatic NSCLC who have received atleast one prior systemic therapy. ⁣ ⁣ Backed by the CodeBreaK 100 trial, this marks a key step forward for precision oncology in India.⁣ ⁣ #CDSCO #Sotorasib #KRASG12C #NSCLC #LungCancer #PrecisionOncology #Oncology #CancerCare #DrugApproval

Post content